{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c", "Q3", 401105121, "MARSHALL & POPP, LLC", 203235, "GENENTECH, INC.", 2023, "third_quarter", "2023-10-19T09:48:22-04:00", 60000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c/\", \"filing_uuid\": \"3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2023, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"60000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Beth Anne Cole\", \"dt_posted\": \"2023-10-19T09:48:22-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"880 New Jersey Avenue, SE\", \"registrant_address_2\": \"Unit 927\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20003\", \"registrant\": {\"id\": 401105121, \"url\": \"https://lda.senate.gov/api/v1/registrants/401105121/\", \"house_registrant_id\": 44305, \"name\": \"MARSHALL & POPP, LLC\", \"description\": \"â\\u20ac\\u2039Government affairs and consulting firm.\", \"address_1\": \"880 New Jersey Avenue, SE\", \"address_2\": \"Unit 927\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20003\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"BETH ANNE COLE\", \"contact_telephone\": \"+1 202-321-1811\", \"dt_updated\": \"2026-01-08T08:41:17.977964-05:00\"}, \"client\": {\"id\": 203235, \"url\": \"https://lda.senate.gov/api/v1/clients/203235/\", \"client_id\": 51, \"name\": \"GENENTECH, INC.\", \"general_description\": \"Biotechnology company.\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2019-03-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act, S.1339 - Pharmacy Benefit Manager Reform Act, H.R. 2679, the PBM Accountability Act, H.R.4822 - Health Care Price Transparency Act. Issues related to the 340B program, including H.R. 3290, to ensure transparency and oversight of the 340B drug discount program. Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 70852, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HAZEN\", \"nickname\": null, \"middle_name\": \"CLAY\", \"last_name\": \"MARSHALL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles\", \"new\": false}, {\"lobbyist\": {\"id\": 70067, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MONICA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"POPP\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CPT\", \"general_issue_code_display\": \"Copyright/Patent/Trademark\", \"description\": \"Issues related to intellectual property and patent reform, including: S.150, Affordable Prescriptions for Patients Act; S.79, Interagency Patent Coordination and Improvement Act; S.113, Prescription Pricing for the People Act; S.142, Preserve Access to Affordable Generics and Biosimilars Act; and S.148, Stop STALLING Act.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 70852, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HAZEN\", \"nickname\": null, \"middle_name\": \"CLAY\", \"last_name\": \"MARSHALL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 70067, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MONICA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"POPP\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TRD\", \"general_issue_code_display\": \"Trade (domestic/foreign)\", \"description\": \"Issues related to waiving intellectual property protections for COVID-19 vaccines under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement).\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 70852, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HAZEN\", \"nickname\": null, \"middle_name\": \"CLAY\", \"last_name\": \"MARSHALL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 70067, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MONICA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"POPP\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c"], "units": {}, "query_ms": 1.8575499998405576, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}